Semaglutide, the active ingredient in Ozempic and Wegovy, reduces appetite and slows stomach emptying through GLP-1 receptor activation
Experience a noticeable glow-up from within, more energy, clearer skin, and better resilience against aging and illness
Starting with a 0.25 mg dose, patients typically increase their dose every 4 weeks until they reach a maintenance dose of 0.5 mg, 1.0 mg, or 2.0 mg, depending on their individual glycemic control needs
This ensures precise management of your condition, tailored to your specific needs, enhancing overall treatment effectiveness
Exenatide Overview : Exenatide, like semaglutide, is a GLP-1 receptor agonist used for diabetes management Pros : Effective for blood sugar control and potential weight loss Cons : Requires injections, and it may have side effects 5